A randomized controlled trial in 234 military personnel and veterans from four Texas locations found clinically significant reductions in PTSD symptoms in more than 60 percent of patients and ...

A lab at the University of Idaho will use a Department of Defense grant to develop machine learning models that might be able ...

A new study published last week suggests the psychedelic drug MDMA, also known as Ecstasy or Molly, can reduce symptoms of post-traumatic stress disorder, and some expect the treatment to be approved ...

NEW YORK, Jan. 19, 2022 /PRNewswire/ -- Neurovation Labs, Inc., a biotech company targeting physical biomarkers of PTSD for comprehensive diagnosis and treatment, today announced that the U.S. Patent ...

The U.S. Department of Veterans Affairs advocates standard treatments for PTSD, including "exposure-based" treatments, which involve having sufferers repeatedly re-experience the traumatic event. The ...

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Neurovation Labs, Inc., a biotechnology company targeting physiological biomarkers of Post-traumatic Stress Disorder (PTSD) for comprehensive diagnosis and ...